Trial Profile
A Phase IIa, Single Centre, Open Label Study to Characterize the Safety of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs NTx 265 (Primary) ; Chorionic gonadotropin; Erythropoietins
- Indications Traumatic brain injuries
- Focus Adverse reactions
- 29 Jan 2010 New trial record